Navigation Links
Concord Medical Announces First Quarter 2010 Financial Results
Date:5/27/2010

BEIJING, May 27 /PRNewswire-Asia-FirstCall/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM), the operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced its unaudited financial results for the first quarter ended March 31, 2010(1).

    First Quarter Fiscal 2010 Highlights

    -- Total net revenues in the first quarter of 2010 were RMB76.2 million
       ($11.2 million), a 36.6% increase from the corresponding period in 2009.
    -- Gross profit in the first quarter of 2010 was RMB49.1 million ($7.2
       million), a 30.4% increase from the corresponding period in 2009.
    -- Non-GAAP Net income(2) in the first quarter of 2010 was RMB24.2 million
       ($3.5 million), a 10.7% increase from the corresponding period in 2009.
    -- Both Non-GAAP basic and diluted earnings per American Depository Share
       ("ADS")(3) for the first quarter of 2010 were RMB0.49 ($0.07).
    -- Adjusted EBITDA(4) (non-GAAP) in the first quarter of 2010 was RMB57.9
       million ($8.5 million), a 19.8% increase from the corresponding period
       in 2009.
    -- Concord Medical opened one center in the first quarter of 2010,
       bringing the total number of centers in operation to 89 across 37
       cities in China, as of March 31, 2010. To date, the Company has entered
       into agreements to establish 38 new centers.
    -- The number of treatment patient cases and diagnostic patient cases was
       6,868 and 26,562 during the first quarter of 2010, respectively.
       Treatment patient cases increased by 18.2% from the corresponding
       period in 2009. Diagnostic patient cases increa
'/>"/>
SOURCE Concord Medical Services Holdings Limited
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. Concord Medical to Report Fourth Quarter and Fiscal Year 2009 Unaudited Financial Results on Thursday, March 18, 2010
2. Mount Sinai Medical Center Drives Genomic Research Collaboration with Isilon Scale-out NAS
3. SPO Medical Announces Innovative Wellness Bracelet
4. Ziehm Imaging and Pie Medical Imaging Announce Cooperation
5. Dehaier Medical Systems Continues Product Line Expansion. Signs Exclusive Distribution Agreement with HEYER Medical for Respiratory Products in China
6. Biomedical Structures Receives Growth Capital from Ampersand Ventures to Fund Ongoing Expansion
7. Highly Regarded Medical Writer Joins Avant Healthcare Marketing Team
8. Micromet to Provide Update on BiTE Antibody Development Programs at Upcoming Medical Conferences
9. Redsense Medical Receives FDA Clearance for the Redsense Safety Device for Home/Self use During Home Hemodialysis
10. Ultra-Fine Metal Tubing Smoothes the Way for Miniaturized Medical Devices
11. Elekta / Mitsubishi Electric Collaboration Helps Japans Gunma University Heavy Ion Medical Center Launch Advanced Carbon Ion Therapy for Treating Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI ), a ... of innovative therapeutics addressing cancer and other unmet medical ... on China , announced today that ... the Company,s application to conduct a Phase 2 global ... for its proprietary drug candidate ENMD-2076.  ...
(Date:3/30/2015)... March 30, 2015  Spherix Incorporated (Nasdaq: ... the fostering and monetization of intellectual property, today ... No. 3:13-cv-03494-M and  Spherix v. Uniden , Case ... Court for the Northern District of ... Spherix v. Verizon, Case No. 1:14-cv-00721-GBL-TCB, in ...
(Date:3/30/2015)... March 30, 2015  Naldemedine, an investigational peripherally ... Shionogi & Co., Ltd., met its primary and ... I) for the treatment of opioid-induced constipation (OIC) ... opioid therapy. Study results showed that naldemedine (0.2 ... the frequency of spontaneous bowel movement (SBM) compared ...
(Date:3/29/2015)... 29, 2015  Caris Life Sciences® today announced ... Molecular Intelligence®, the company,s panomic, comprehensive tumor profiling ... several rare and difficult to treat gynecological cancers ... potential to improve patient outcomes. These studies were ... Society of Gynecologic Oncology (SGO) 2015 Annual Meeting ...
Breaking Biology Technology:CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 2CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 3CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 4CASI Pharmaceuticals Receives Approval From CFDA For Phase 2 Clinical Trial In China With ENMD-2076 For Ovarian Clear Cell Carcinoma 5Spherix Provides Update on Litigation vs. VTech, Uniden and Verizon 2Spherix Provides Update on Litigation vs. VTech, Uniden and Verizon 3Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 2Shionogi & Co., Ltd. Announces That Naldemedine Meets Primary Endpoint In A Phase 3 Study For The Treatment Of Opioid-Induced Constipation 3Caris Molecular Intelligence Facilitates Comparison of Biomarker Profiles to Inform Targeted Treatment Strategies in Distinct Gynecological Cancers 2Caris Molecular Intelligence Facilitates Comparison of Biomarker Profiles to Inform Targeted Treatment Strategies in Distinct Gynecological Cancers 3Caris Molecular Intelligence Facilitates Comparison of Biomarker Profiles to Inform Targeted Treatment Strategies in Distinct Gynecological Cancers 4
... Dynamics International (CDI), the world,s largest producer of ... today announced the publication of research demonstrating an efficient ... induced pluripotent stem cells (iPSCs) under a feeder-free condition ... 1 in PLoS ONE , will likely be ...
... TRIANGLE PARK, N.C. March 4, 2011 Grifols S.A. (GRF.MC) ... today announced that the outside date under their merger agreement ... June 30, 2011 (from March 6, 2011). Grifols has extended ... 30, as well. Grifols is continuing to work with the ...
... Limited (ASX: HZL; OTCQX: HLTZY) announced that it has ... LLC ("the Trout Group"), a leading New York-based investor ... provide investor relations services for Healthzone for an initial ... 60 current clients, the Trout Group provides investor relations ...
Cached Biology Technology:Cellular Dynamics International Scientists Report on Efficient Method to Produce Footprint-Free Induced Pluripotent Stem Cells (iPSCs) Under Feeder-Free Conditions 2Cellular Dynamics International Scientists Report on Efficient Method to Produce Footprint-Free Induced Pluripotent Stem Cells (iPSCs) Under Feeder-Free Conditions 3Grifols and Talecris Announce the Outside Date of Their Merger Agreement has been Extended to June 30, 2011 2Healthzone Limited Engages The Trout Group for Investor Relations Services 2
(Date:3/12/2015)... , March 12, 2015 WHEN:Tuesday, March ... Registration here: http://bit.ly/1G7Os0L . SPEAKERS: , Frost ... SeshagiriPhoto - http://photos.prnewswire.com/prnh/20150311/181111 Biometric ... to compete in several different markets and industries. ... currently witnessing an uptrend. Join ...
(Date:3/10/2015)... 10, 2015  Continuing its 167-year history of offering ... introduces The Eye Scanning Password Authenticator , a ... to secure websites or sensitive data. Employing ... international borders, the device has a small camera that ... the iris, converting them into an encrypted ID that ...
(Date:3/10/2015)... , March 10, 2015  NXT-ID, Inc. (NASDAQ: ... the "Company"), a biometric authentication company focused on ... Wocket™ smart wallet has been named the "Number ... Modern. Rethink Modern ( http://www.rethinkmodern.com/ ) ... for your home and lifestyle that have a unique ...
Breaking Biology News(10 mins):Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 2Biometrics Key to Future Growth in Healthcare, Retail and Financial Markets 3Hammacher Schlemmer Introduces The Eye Scanning Password Authenticator 2NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 2NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 3NXT-ID's Wocket Smart Wallet Named Number One Best Tech Gift for 2015 by Rethink Modern 4
... collaborating at Cornell University in Ithaca and Weill Cornell ... panel of 23 protein biomarkers in cerebrospinal fluid that ... someday to identify patients living with Alzheimer's disease. , ... of the journal Annals of Neurology. , ...
... Manchester have been awarded £130,000 to develop new techniques ... , Current checks to establish whether a new drug ... on live animals to establish whether they are harmful ... at the University spin-out company he founded, Gentronix, have ...
... HI ?December 12, 2006 -- A new study in Journal ... consistently win over smaller shrimp of the same gender when ... shrimp ?even though adult males of the species are typically ... , "Both size and gender are important factors in acquiring ...
Cached Biology News:Protein 'fingerprint' in spinal fluid could spot Alzheimer's disease 2Protein 'fingerprint' in spinal fluid could spot Alzheimer's disease 3New research to cut animal testing 2
Human Apolipoprotein B100 Affinity Purified Polyclonal Ab ENTREZ GeneID: 338...
Mouse Ameloblastin Biotinylated Affinity Purified PAb ENTREZ GeneID: 11698...
Human SOST Affinity Purified Polyclonal Ab...
Homo sapiens CDC23 (cell division cycle 23, yeast, homolog),...
Biology Products: